VBI Vaccines Inc. (Nasdaq: VBIV and TSX: VBV) (“VBI”) will host a hepatitis B (“HBV”) Key Opinion Leader meeting on Monday, June 13 at 12:00 PM ET. The event is being held at the Lotte New York Palace in New York City.
The event will feature keynote presentations by Dr. Daniel Shouval, M.D. and Dr. Florian Schödel, M.D., who will discuss new approaches to vaccination against hepatitis B as well as the unmet medical need. In addition, members of the VBI management team will provide an overview of Sci-B-Vac®, a third-generation HBV vaccine that mimics all three viral surface antigens of the hepatitis B virus. Sci-B-Vac is approved in Israel and in 14 other countries and has demonstrated a favorable safety and efficacy profile in over 300,000 patients. Download Presentation PDFAt the time of the event, a live webcast will be available at: http://lifesci.rampard.com/20160613/reg.jsp
Dr. Shouval is a Professor of Medicine and the former Dean of the Faculty of Medicine at the Hebrew University and Hadassah Medical School in Jerusalem, where he established Israel’s first liver unit in 1983. He is a visiting Professor at Albert Einstein College of Medicine and has held similar positions at Harvard Medical School, Massachusetts General Hospital, and the University of Paris. Dr. Shouval currently serves as a standing adviser to the European Viral Hepatitis Prevention Board and the World Health Organization (“WHO”), and has previously served as both President and Chairman of the Educational Committee of the European Association for the Study of the Liver (“EASL”).
Dr. Schödel has more than 20 years of pharmaceutical, biotech industry, and academic experience leading teams in the development of vaccines and biologics. A physician and microbiologist by training, Dr. Schödel holds adjunct faculty appointments at the University of Munich and at the Biodesign Center of ASU. Dr. Schödel’s research has focused on novel recombinant vaccines against diseases including hepatitis B, malaria, and typhoid. He has led the clinical teams responsible for several successful vaccine filings in the U.S., the European Union, and globally, including several pediatric combination vaccines.
The event is intended for institutional investors and sell-side analysts only. If you would like to attend, please contact Mac MacDonald at (212) 915-2567 or via e-mail at firstname.lastname@example.org.
- Event: Hepatitis B Key Opinion Leader Meeting
- Date: Monday, June 13, 2016
- Time: 12:00 PM ET – 1:30 PM ET
- Location: Lotte New York Palace in New York, NY
- Webcast: http://lifesci.rampard.com/20160613/reg.jsp